Quest Diagnostics CEO Stephen Rusckowski's 2019 pay rises 2% to $10M
Quest Diagnostics reports 2019 executive compensation
By ExecPay News
Published: April 8, 2020
Quest Diagnostics reported fiscal year 2019 executive compensation information on April 8, 2020.
In 2019, five executives at Quest Diagnostics received on average a compensation package of $4.8M, a 11% increase compared to previous year.
Stephen H. Rusckowski, Chief Executive Officer, received $10M in total, which increased by 2% compared to 2018. 43% of Rusckowski's compensation, or $4.3M, was in stock awards. Rusckowski also received $1.4M in non-equity incentive plan, $3M in option awards, $1.1M in salary, as well as $257K in other compensation.
Manuel O. Mendez, Senior Vice President and Chief Commercial Officer, received a compensation package of $4.6M. 63% of the compensation package, or $2.9M, was in stock awards.
Mark J. Guinan, Chief Financial Officer, earned $3.3M in 2019, a 3% increase compared to previous year.
James E. Davis, Executive Vice President, General Diagnostics, received $3.1M in 2019, which increases by 2% compared to 2018.
Carrie Eglinton Manner, Senior Vice President, Advanced Diagnostics, earned $2.7M in 2019, a 7% decrease compared to previous year.
Related executives
Stephen Rusckowski
Quest Diagnostics
Chief Executive Officer
Mark Guinan
Quest Diagnostics
Chief Financial Officer
Manuel Mendez
Quest Diagnostics
Former Senior Vice President and Chief Commercial Officer
James Davis
Quest Diagnostics
Chief Executive Officer
Carrie Manner
Quest Diagnostics